Home R&D Page 11

R&D

Empagliflozin: new results showing the reduction of cardiovascular events

Cristiana Bernini -

ODYSSEY: a study to assess the potenital cardiovascular benefit of alirocumab

Cristiana Bernini -

Conditional approval for blinatumomab to treat B-precursor ALL

Cristiana Bernini -

Mepolizumab in the treatment of asthma

Cristiana Bernini -

First digital medicine application accepted by FDA

Cristiana Bernini -
Clinical research

Children are not small adults

Almost all drugs used for the treatment of childhood cancer have not been studied in the pediatric population
Cristiana Bernini -

Guanfacine to treat attention deficit hyperactivity disorder

Cristiana Bernini -

Alirocumab to treat adults with primary hypercholesterolaemia

Cristiana Bernini -

Association tiotropium / olodaterol improves the quality of life in COPD

Cristiana Bernini -

Hemophilia A: confirmed efficacy and long term safety of rFVIIIFc

Cristiana Bernini -
1...101112...17Page 11 of 17
© © 2026 Tecniche Nuove Spa - All rights reserved. Registered office: Via Eritrea 21 - 20157 Milan. Share capital: 5,000,000 Euro fully paid up. Tax code, VAT number and registration with the Milan Register of Companies: 00753480151